These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24580504)

  • 1. Accelerating the introduction of rotavirus immunization in Indonesia.
    Suwantika AA; Zakiyah N; Lestari K; Postma MJ
    Expert Rev Vaccines; 2014 Apr; 13(4):463-72. PubMed ID: 24580504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus vaccines in Belgium: policy and impact.
    Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.
    Nakagomi T; Cuevas LE; Gurgel RG; Elrokhsi SH; Belkhir YA; Abugalia M; Dove W; Montenegro FM; Correia JB; Nakagomi O; Cunliffe NA; Hart CA
    Arch Virol; 2008; 153(3):591-3. PubMed ID: 18175037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghana and Rwanda expand national immunization programs.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Jul; 8(7):848. PubMed ID: 23213664
    [No Abstract]   [Full Text] [Related]  

  • 6. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.
    Linhares AC; Justino MC
    Expert Rev Vaccines; 2014 Jan; 13(1):43-57. PubMed ID: 24308577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccines WHO position paper: January 2013 - Recommendations.
    Vaccine; 2013 Dec; 31(52):6170-1. PubMed ID: 23746456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccination within the South African Expanded Programme on Immunisation.
    Seheri LM; Page NA; Mawela MP; Mphahlele MJ; Steele AD
    Vaccine; 2012 Sep; 30 Suppl 3():C14-20. PubMed ID: 22939015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of a universal rotavirus immunization program in Japan.
    Sato T; Nakagomi T; Nakagomi O
    Jpn J Infect Dis; 2011; 64(4):277-83. PubMed ID: 21788701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.
    Kirkwood CD; Boniface K; Barnes GL; Bishop RF
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S48-53. PubMed ID: 21183840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1611-4. PubMed ID: 22129995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece.
    Syriopoulou V; Kafetzis D; Theodoridou M; Syrogiannopoulos GA; Mantagos S; Trimis G; Mavrikou M; Konstantopoulos A
    Acta Paediatr; 2011 May; 100(5):732-9. PubMed ID: 21223372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
    Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
    Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012.
    Tate JE; Haynes A; Payne DC; Cortese MM; Lopman BA; Patel MM; Parashar UD
    Pediatr Infect Dis J; 2013 Jul; 32(7):741-4. PubMed ID: 23426425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should rotavirus vaccines be included in the national immunization program of a small developed country?
    Milne R; Grimwood K
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):401-4. PubMed ID: 19817522
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.
    Madhi SA; Bamford L; Ngcobo N
    S Afr Med J; 2014 Mar; 104(3 Suppl 1):228-34. PubMed ID: 24893498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?
    Deen J; Lopez AL; Kanungo S; Wang XY; Anh DD; Tapia M; Grais RF
    Hum Vaccin Immunother; 2018 Feb; 14(2):495-499. PubMed ID: 29135339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
    Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A
    Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.